Clinical trial
Effectiveness of Ropinirole and Gabapentin for the Treatment of Restless Legs Syndrom in Patients on Maintenance Hemodialysis: a Randomized, Blinded, Placebo-Controlled Trial
NCT03708237 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Ropinirole and Gabapentin for the Treatment of Restless Legs Syndrom in Patients on Maintenance Hemodialysis: a Randomized, Blinded, Placebo-Controlled Trial
- Lead sponsor
- University of Alberta
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- February 19, 2019
- Completion date
- December 11, 2019
- Enrollment
- 3 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease, restless legs syndrome